EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bdellovibrio bacteriovorus Patches Accelerate Wound Closure in Diabetic Mice Faster than Conventional Antibiotic Therapy

Christian Mariel Sáenz-Santos, Yunia Verónica García-Tejeda, Mario Alberto Rodríguez-Pérez, Rosario Munguía-Fuentes, Carolina Estefania Chávez-Murillo, Oscar Eduardo Cigarroa-Mayorga

Applied Sciences · 29.03.2026 · 16 (7) · 3305

DOI: 10.3390/app16073305 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Sciences, online erschienen am 29.03.2026. Verfasst von Christian Mariel Sáenz-Santos und 5 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Secretaría de Investigación y Posgrado del Instituto Politécnico Nacional.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic wounds infected with multidrug-resistant bacteria represent a major clinical challenge due to delayed healing and limited therapeutic options. In this study, we evaluated the therapeutic efficacy and biosafety of a biopolymeric skin patch loaded with the predatory bacterium Bdellovibrio bacteriovorus HD100 in a murine model of diabetic wounds infected with Pseudomonas aeruginosa. In vitro assays demonstrated that B. bacteriovorus HD100 reduced P. aeruginosa populations by approximately 3 log units within 48 h. In vivo, diabetic mice treated with the B. bacteriovorus-loaded patch achieved complete wound closure within 12±1 days, compared with 16±1 days in mice treated with conventional antibiotic therapy (piperacillin/tazobactam, 16 mg/kg; single dose). Non-diabetic mice treated with biopolymeric patches, with or without the predatory bacterium, exhibited complete wound closure within 9–10 days. Molecular analysis by PCR revealed no detectable dissemination of B. bacteriovorus DNA to internal organs (liver, spleen, kidney, or brain), indicating the systemic biosafety of topical application. Overall, these results demonstrate that B. bacteriovorus-based skin patches significantly accelerate wound closure in infected diabetic wounds and represent a promising localized biological alternative to conventional antibiotic therapy.

Förderung

  • Secretaría de Investigación y Posgrado del Instituto Politécnico Nacional

Zitieren

APA

Sáenz-Santos, C. M., García-Tejeda, Y. V., Rodríguez-Pérez, M. A., Munguía-Fuentes, R., Chávez-Murillo, C. E., & Cigarroa-Mayorga, O. E. (2026). Bdellovibrio bacteriovorus Patches Accelerate Wound Closure in Diabetic Mice Faster than Conventional Antibiotic Therapy. Applied Sciences, 16(7), 3305. https://doi.org/10.3390/app16073305

Vancouver

Sáenz-Santos CM, García-Tejeda YV, Rodríguez-Pérez MA, Munguía-Fuentes R, Chávez-Murillo CE, Cigarroa-Mayorga OE. Bdellovibrio bacteriovorus Patches Accelerate Wound Closure in Diabetic Mice Faster than Conventional Antibiotic Therapy. Applied Sciences. 2026;16(7):3305. doi:10.3390/app16073305

BibTeX
@article{SenzSantos2026,
  author = {Sáenz-Santos, Christian Mariel and García-Tejeda, Yunia Verónica and Rodríguez-Pérez, Mario Alberto and Munguía-Fuentes, Rosario and Chávez-Murillo, Carolina Estefania and Cigarroa-Mayorga, Oscar Eduardo},
  title = {Bdellovibrio bacteriovorus Patches Accelerate Wound Closure in Diabetic Mice Faster than Conventional Antibiotic Therapy},
  journal = {Applied Sciences},
  year = {2026},
  volume = {16},
  number = {7},
  pages = {3305},
  doi = {10.3390/app16073305}
}
Kostenlos starten →